RIPK2 and triple-negative breast carcinoma: The expression of RIPK2 in triple-negative breast cancer is higher than that of other molecular subtypes, and this high expression is related to the prognosis of triple-negative breast cancer [26], which may indicate that the abnormal expression of RIPK2 is one of the main factors leading to the poor prognosis of triple-negative breast cancer.